Stock Analysts

Alibaba Group (BABA) Lags Q3 Earnings on High Expenses

Alibaba Group Holding Limited ( BABA ) reported third-quarter fiscal 2015 (ended Dec 31, 2014) earnings of 55 cents per share, which missed the Zacks Consensus Estimate of 62 cents due to increased investments in mobile, marketing and other new ventures. The adjusted earnings per share exclude one-time items but include stock-based compensation expense. […]

Technicals

AbbVie (ABBV) Tops 4Q Earnings Estimates, Affirms View – Tale of the Tape

North Chicago, IL-based AbbVie ( ABBV ), which has been in the news thanks to the recent approval of its hepatitis C virus (HCV) treatment Viekira Pak, is best known for its autoimmune disease drug, Humira. Humira, the company’s flagship product which is approved for a wide range of indications, is a major contributor to AbbVie’s top line. While Humira will remain the key growth driver at AbbVie, the coming quarters will see investor focus remaining primarily on the initial response to the Viekira Pak launch as well as the company’s sales expectations for 2015. […]